Article: Emerging Opportunities in Controlled-Release Generic Drugs: New Report Identifies 30 Controlled-Release Drugs Valued at US$15 Billion.

M2 PRESSWIRE-1 September 2009-Research and Markets: Emerging Opportunities in Controlled-Release Generic Drugs: New Report Identifies 30 Controlled-Release Drugs Valued at US$15 Billion(C)1994-2009 M2 COMMUNICATIONS

RDATE:01092009

Dublin - Research and Markets (http://www.researchandmarkets.com/research/a76737/emerging_opportuni) has announced the addition of the "Emerging Opportunities in Controlled-Release Generic Drugs" report to their offering.

This new report identifies 30 controlled-release drugs valued at US$15 billion, many of which will be losing patent protection in the medium term.

From emerging specialist companies to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!